Wed, March 22, 2023

Jonathan Wolleben Reiterated (ALT) at Buy and Held Target at $26 on, Mar 22nd, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-26-on-mar-22nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Jonathan Wolleben of JMP Securities, Reiterated "Altimmune, Inc." (ALT) at Buy and Held Target at $26 on, Mar 22nd, 2023.

Jonathan has made no other calls on ALT in the last 4 months.



There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Thursday, March 9th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Wednesday, January 18th, 2023